Butorphanol (Stadol)

Category:

  • Analgesic

Description:

  • Partial opiate agonist analgesic

Indications:

  • Moderate to severe pain (surgical, cancer, burns)

  • Migraine headache (nasal inhaler)

Contraindications:

  • Patients with impaired respiratory function.

Precautions:

  • Pregnancy Category C 

  • Patients will experience CNS effects of drowsiness and dizziness, therefore use caution with motor vehicle operation or other hazardous tasks.

  • Low physical dependence, however use in caution with unstable or history of abuse patients.

  • Avoid prolonged, sustained usage to decrease addiction potential.

  • Geriatric patients may have decreased medication clearance and elimination, therefore dosage must be modified.

  • Use with caution with other CNS depressive medications.

Adverse Reactions (Side Effects):

  • Sedation (43%)

  • Dizziness (19%)

  • Nausea and vomiting (13%)

Dosage:

Administered by injection (IM or IV) or nasal inhalation, adjusted to severity of pain

Adult:

  • Initial dose: 2mg IM or 1mg IV, repeated q3-4h as needed

  • Maintenance: 1-4mg IM or 0.5-2mg IV q3-4h

  • Inhalation: 1 spray (1mg per spray) in each nostril, if pain control not achieved then repeat with one spray in one nostril in 60-90 minutes, then q3-4h if needed

Geriatric or Impaired Hepatic or Renal Function:

  • One-half ( ½ ) normal dose IM or IV

  • Inhalation: 1 spray (1mg per spray) in each nostril, if pain control not achieved then repeat with one spray in one nostril in 90-120 minutes, then q6h if needed

 

 

 

Home  ·  Military Medicine  ·  Sick Call  ·  Basic Exams  ·  Medical Procedures  ·  Lab and X-ray  ·  The Pharmacy  ·  The Library  ·  Equipment  ·  Patient Transport  ·  Medical Force Protection  ·  Operational Safety  ·  Operational Settings  ·  Special Operations  ·  Humanitarian Missions  ·  Instructions/Orders  ·  Other Agencies  ·  Video Gallery  ·  Forms  ·  Web Links  ·  Acknowledgements  ·  Help  ·  Feedback

Approved for public release; Distribution is unlimited.

The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks.

Source: Operational Medicine 2001, Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300.

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates, LLC.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. The medical information presented was reviewed and felt to be accurate in 2001. Medical knowledge and practice methods may have changed since that time. Some links may no longer be active. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

© 2015, Brookside Associates, LLC. All rights reserved

Other Brookside Products

 

 

Advertise on this site